Gemtuzumab ozogamicin with cytarabine and mitoxantrone as a third-line treatment in a poor prognosis group of adult acute myeloid leukemia patients: a single-center experience.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples